BOULDER, Colo., Sept. 25, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will hold a conference call to discuss preliminary results from two melanoma trials and a colorectal cancer trial on Monday, September 28, 2015. Ron Squarer, Chief Executive Officer, and Victor Sandor, M.D., Chief Medical Officer, will lead the call.

http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO

The trials include a Phase 2 combination trial of binimetinib and encorafenib in BRAF-mutant melanoma patients (LOGIC2), a Phase 1b/2 combination trial of binimetinib and a CDK4/6 inhibitor in NRAS-mutant melanoma patients and a Phase 2 combination trial of encorafenib and an EGFR inhibitor with or without the addition of a PI3K inhibitor in patients with BRAF-mutant colorectal cancer. Data from these trials will be presented at the European Society of Medical Oncology's (ESMO) annual European Cancer Conference (ECC) or were presented at the 2015 ESMO World Congress of Gastrointestinal Cancer. 



    Conference Call Information

    Date:                           Monday, September 28, 2015

    Time:                           9:00 a.m. eastern time

    Toll-Free:                      (844) 464-3927

    Toll:                           (765) 507-2598

    Pass Code:                                                     43837177

    Webcast, including Replay and Conference Call Slides:  http://
     edge.media-server.com/m/p/ky8z35w4/lan/en

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.



    CONTACT:                        Tricia Haugeto

                                    Array BioPharma Inc.

                                    (303) 386-1193

                                    thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-hold-conference-call-to-discuss-clinical-data-presentations-in-melanoma-and-colorectal-cancer-on-september-28-2015-300149033.html

SOURCE Array BioPharma